CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watson, J. T.
Right arrow Articles by Ali, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watson, J. T.
Right arrow Articles by Ali, M. J.

Canadian Journal of Anesthesia, Vol 37, 798-800, Copyright © 1990 by Canadian Anesthesiologists' Society

ARTICLES

The prophylactic use of octreotide in a patient with ovarian carcinoid and valvular heart disease

JT Watson, NH Badner and MJ Ali
Department of Anaesthesia, University Hospital, University of Western Ontario, London.

This case report describes the use of octreotide, a long-acting somatostatin analogue, in the management of a patient with an ovarian carcinoid tumour and severe cardiac valvular disease. This patient underwent laparotomy and tumour resection without complication. Anaesthesia was induced with midazolam, fentanyl, and vecuronium, and maintained with isoflurane as well as additional fentanyl and vecuronium. However, we feel that it was the use of octreotide that prevented a life-threatening crisis intraoperatively, and recommend its use in patients with carcinoid syndrome undergoing anaesthesia and surgery.


This article has been cited by other articles:


Home page
 Canadian J. AnesthesiaHome page
S. Orbach-Zinger, R. Lombroso, and L. A. Eidelman
Uneventful spinal anesthesia for a patient with carcinoid syndrome managed with long-acting octreotide: [Une rachianesthesie sans incident realisee avec l'octreotide a action prolongee chez un patient atteint d'un syndrome carcinoide]
Can J Anesth, August 1, 2002; 49(7): 678 - 681.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
M. A. O. Kinney, M. E. Warner, D. M. Nagorney, J. Rubin, D. R. Schroeder, P. M. Maxson, and M. A. Warner
Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours{dagger}
Br. J. Anaesth., September 1, 2001; 87(3): 447 - 452.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
D Vergani, L Massironi, F Lombardi, and C Fiorentini
Carcinoid heart disease from ovarian primary presenting with acute pericarditis and biventricular failure
Heart, December 1, 1998; 80(6): 623 - 626.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the Canadian Anesthesiologists' Society.